Elisabeth Geyer Prinslow is an author at AbbVie (United States) specializing in synthetic biology, nanotherapeutics, and immunoengineering.
Top concepts
MedicineImmunologyMicrobiologyBiotechnologyImmunotherapyPeptide ScienceSmall MoleculesNanotherapeuticsNatural SciencesImmunoengineering
Publications per year
2023–2023
1
1
“Stapling” scFv for multispecific biotherapeutics of superior properties
Lauren Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp et al. · mAbs · 2023 · 25 citations · Full text
Rows per page
1–1 of 1